These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37453470)

  • 1. Homocysteine as a trigger and potential therapeutic target for autoimmune diseases.
    Hu X; Wang JB; Zhao Y; Fang Y; Chen C; Ge M; Xu YQ; Gao ZX; Pan HF; Wang P
    Autoimmun Rev; 2023 Sep; 22(9):103389. PubMed ID: 37453470
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
    Oussalah A; Guéant JL; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2011 Nov; 34(10):1173-84. PubMed ID: 21967576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinaemia as a cardiovascular risk factor: an update.
    van der Griend R; Biesma DH; Banga JD
    Neth J Med; 2000 Mar; 56(3):119-30. PubMed ID: 10759023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary diversity no longer offsets the mortality risk of hyperhomocysteinaemia in older adults with diabetes: a prospective cohort study.
    Wahlqvist ML; Xiu L; Lee MS; Chen RC; Chen KJ; Li D
    Asia Pac J Clin Nutr; 2016; 25(2):414-23. PubMed ID: 27222426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cardiometabolic risk profile with prehypertension accompany hyperhomocysteinaemia.
    Chen H; Sun Y; Wang X; Si Q; Yao W; Wan Z
    Clin Exp Hypertens; 2015; 37(3):218-22. PubMed ID: 25051302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine loading does not enhance the predictive value of homocysteine serum testing for all-cause mortality or major adverse cardiac events.
    Dunkelgrun M; Hoeks SE; Schouten O; Feringa HH; Welten GM; Vidakovic R; van Gestel YR; van Domburg RT; Goei D; de Jonge R; Lindemans J; Poldermans D
    Intern Med J; 2009 Jan; 39(1):13-8. PubMed ID: 18336539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinaemia in Behçet's disease.
    Aksu K; Turgan N; Oksel F; Keser G; Ozmen D; Kitapçioğlu G; Gümüşdiş G; Bayindir O; Doğanavşargil E
    Rheumatology (Oxford); 2001 Jun; 40(6):687-90. PubMed ID: 11426028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and arterial thrombosis: Challenge and opportunity.
    Di Minno MN; Tremoli E; Coppola A; Lupoli R; Di Minno G
    Thromb Haemost; 2010 May; 103(5):942-61. PubMed ID: 20352150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinaemia is associated with biochemical hyperandrogenaemia in women with reproductive age.
    Lin YH; Huang SY; Hsu MI; Chang YC; Cheng CY; Hsu CS; Tzeng CR
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):314-8. PubMed ID: 24169034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hyperhomocysteinaemia, selected determinants and relation to hypertension severity in Northern-Nigerian hypertensives: the ABU homocysteine survey.
    Onyemelukwe OU; Maiha BB
    Ghana Med J; 2020 Mar; 54(1):17-29. PubMed ID: 32863409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine: an independent risk factor for the failure of vascular intervention.
    Currie IC; Wilson YG; Scott J; Day A; Stansbie D; Baird RN; Lamont PM; Tennant WG
    Br J Surg; 1996 Sep; 83(9):1238-41. PubMed ID: 8983615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease.
    Stehouwer CD; Jakobs C
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S107-11. PubMed ID: 9587036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for mild hyperhomocysteinaemia as a risk factor.
    Boers GH
    J Inherit Metab Dis; 1997 Jun; 20(2):301-6. PubMed ID: 9211202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
    den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Haak HL; Wijermans PW; Bos GM
    Lancet; 1995 Apr; 345(8954):882-5. PubMed ID: 7707810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens.
    van der Griend R; Biesma DH; Banga JD
    Vasc Med; 2002 Feb; 7(1):29-33. PubMed ID: 12083731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinaemia and vascular disease.
    Townend J; O'Sullivan J; Wilde JT
    Blood Rev; 1998 Mar; 12(1):23-34. PubMed ID: 9597195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
    Unlü Y; Keleş S; Becit N; Koçoğullari CU; Koçak H; Bakan E
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):315-8. PubMed ID: 15963742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia.
    Møller J; Nielsen GM; Tvedegaard KC; Andersen NT; Jørgensen PE
    Scand J Clin Lab Invest; 2000 Oct; 60(6):491-9. PubMed ID: 11129065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hyperhomocysteinaemia in children with stroke.
    Cardo E; Vilaseca MA; Campistol J; Artuch R; Colomé C; Pineda M
    Eur J Paediatr Neurol; 1999; 3(3):113-7. PubMed ID: 10461566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors.
    Brattström L; Lindgren A; Israelsson B; Malinow MR; Norrving B; Upson B; Hamfelt A
    Eur J Clin Invest; 1992 Mar; 22(3):214-21. PubMed ID: 1582447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.